Home » Newsletters » BioWorld Science

BioWorld Science

April 15, 1999

View Archived Issues

DiagnoCure develops diagnostic for metastatic prostate cancer cells

SBIR grant to Genetronics for gene therapy delivery research

Steroidogenesis inhibitor tested in mouse model of hereditary blindness

FDA requires further info about Hepagene vaccine

AIDSVAX enters clinical trials at U. of Pittsburgh

Merger plans for Synthelabo and Sanofi

Potent and specific FTase inhibitor presented by Biomeasure

Merck presents protein farnesyltransferase inhibitor in phase I testing

U.S. is country of first launch for single-isomer bronchodilator

PEG-rMETase, a promising new approach to cancer therapy

Preparation, compositions and administration of new carrier compounds reported by Emisphere

Fujirebio presents pyrimidine-based compounds useful for hypoxemia

Neurokinin antagonists for IBS synthesized and evaluated at Solvay

Schering-Plough investigators discover water-soluble salt of antifungal azole

Novel water-soluble camptothecin analogue suitable for formulation in liposomes

Sugen presents preclinical data for SU-6668 at AACR meeting

In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting

Profile of ZD-4190, a potent VEGF receptor tyrosine kinase inhibitor and antiangiogenic agent

News from AACR: Abbott researchers report findings on farnesyltransferase inhibitors

TAS-106, a promising antitumor nucleoside profiled at AACR meeting

Ebastine is not approvable, FDA tells RPR

Ontogen's OC144-093 reported at AACR meeting to merit further clinical testing

Higher dose of Rebif approved in E.U. for multiple sclerosis

Antisense oligonucleotides targeting Bcl-x developed and evaluated at Isis

Elan holds pre-NDA meeting concerning ziconotide

NovoSeven reaches the U.S. hemophilia market

New distamycin derivative PNU-166196 exerts both antiproliferative and apoptotic effects

Celtrix and Elan form joint venture for osteoporosis therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Heartbeam wins appeal, gains FDA clearance
BioWorld MedTech
Management is beaming with delight at Heartbeam Inc. as the company's appeal strategy paid off with U.S. FDA clearance for its synthetic 12-lead electrocardiogram...